Add to my selection

QALSODY (tofersen)

Medicine - Posted on Nov 28 2024

Active substance (DCI)

tofersen

history (2)

11/20/24

QALSODY (tofersen) - Amyotrophic lateral sclerosis (ALS)

Summary of opinion Unfavourable opinion for reimbursement in the treatment of adults with amyotrophic lateral sclerosis (ALS...

CAV :
54321

icône flèche
10/10/24

QALSODY (tofersen) - Sclérose latérale amyotrophique

Autorisation d’accès précoce refusée à la spécialité QALSODY (tofersen) dans l’indication « traitement des adultes atteints ...

icône flèche

Technical information

ATC code

N07XX22

Manufacturer

BIOGEN FRANCE SAS

Presentation

QALSODY 100 mg, solution injectable
1 flacon en verre de 15 ml (CIP : 34009 551 010 3 1)

See also

MISE AU POINT

08/11/2024

Qalsody : mise au point de la HAS

All our publications

Congenital, genetic and rare diseases

Neurodegenerative diseases

Neuromuscular diseases